MedTrace Logo

Improving the Cognitive Accessibility of Self-reports for People With ID

NCT05857592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-05-10

No results posted yet for this study

Summary

In the proposed study, the investigators aim to investigate whether the existing ABAS-3 self-report questionnaire is suitable to be completed meaningfully by individuals who are perceived as having mild intellectual disability (55\<IQ\<85) based on cognitive impairment. Based on the participants' experiences and researchers' expertise, the investigators develop a 'more inclusive' self-report version. The investigators then look at the extent to which participants indicate that they understand this version better, based on user experiences and limited psychometric research. In doing so, the investigators also compare the outcomes of the self-report and informant-report variant.

Conditions

  • Mild Intellectual Disability
  • Borderline Intellectual Functioning

Interventions

DIAGNOSTIC_TEST

Adaptive functioning self-report questionnaire

A self-report questionnaire for assessing level of adaptive functioning

DIAGNOSTIC_TEST

Adaptive functioning self-report questionnaire - adapted

A self-report questionnaire for assessing level of adaptive functioning, adapted to the communication level of the participant

Sponsors & Collaborators

  • University of Amsterdam

    collaborator OTHER

  • Zuyd University of Applied Sciences

    collaborator OTHER

  • Koraal

    lead OTHER

Principal Investigators

  • Roel Kooijmans, MSc · Koraal

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-10-31
Completion
2024-05-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05857592 on ClinicalTrials.gov